Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
2.000
-0.760 (-27.54%)
At close: Oct 7, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $3.21 million as of October 8, 2025. Its market cap has decreased by -87.48% in one year.
Market Cap
3.21M
Enterprise Value
5.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.00
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 3.21M, a decrease of -95.21%. That is a compound annual growth rate of -45.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 3.21M | -36.51% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | 43.76M | -34.67% |
| Oct 20, 2020 | 66.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |